COMPANY

Aprecia Pharmaceuticals

Keywords: drug delivery

Location: Mason, OH · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Aug 19, 2025 Partnership Partnership / licensing announced Aug 19, 2025. Source: company's own press page. source ↗
Jun 27, 2025 FDA FDA New indication / efficacy supplement: SPRITAM (levetiracetam) — NDA207958/27, Jun 27, 2025. Applicant at approval: Aprecia Pharmaceuticals. source ↗

Last 2 years.

Aug 19, 2025 Partnership / licensing announced Aug 19, 2025. Source: company's own press page. source ↗

Jun 27, 2025 FDA New indication / efficacy supplement: SPRITAM (levetiracetam) — NDA207958/27, Jun 27, 2025. Applicant at approval: Aprecia Pharmaceuticals. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12